title: Staib agar supplemented with a triple antibiotic combination for the detection of Cryptococcus neoformans in clinical specimens.
abstract: It was demonstrated that the in vitro growth of a mucoid Escherichia coli strain from the urine of an AIDS patient could disturb the concurrent growth of Cryptococcus neoformans and the development of its brown colour effect (BCE) on Staib agar (syn. Guizotia abyssinica creatinine agar, bird seed agar, niger seed agar etc.) supplemented with penicillin + streptomycin. Owing to the supplementation with the triple antibiotic combination of penicillin + streptomycin + gentamicin and the resulting inhibition of E. coli growth, the formation of an intense BCE of the Cr. neoformans colonies after 3 d at 26 degrees C could be observed. On the same medium supplemented with this triple antibiotic combination 40 Cr. neoformans strains tested showed growth with an intense BCE after 3 d at 26 degrees C; but on Emmons' neutral Sabouraud's dextrose agar (NSDA) supplemented with the same triple antibiotic combination, inhibition of growth was found. For the examination of clinical specimens for Cr. neoformans contaminated with gram-negative rod-like bacteria, Staib agar supplemented with this triple antibiotic combination is proposed. Various antibiotic supplements to primary recovery media for fungi are discussed and ecological interrelations of bacteria and fungi are emphasized.
authors.forename: F
authors.initials: F
authors.lastname: Staib
authors.forename: M
authors.initials: M
authors.lastname: Seibold
authors.forename: E
authors.initials: E
authors.lastname: Antweiler
authors.forename: B
authors.initials: B
authors.lastname: Fröhlich
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000175:diagnosis / Q000382:microbiology / Q000652:urine; D000328:Adult; D000362:Agar; D002176:Candida albicans / Q000187:drug effects / Q000254:growth & development; D003454:Cryptococcus / Q000302:isolation & purification*; D003455:Cryptococcus neoformans / Q000187:drug effects / Q000254:growth & development / Q000302:isolation & purification*; D004359:Drug Therapy, Combination / Q000494:pharmacology*; D004926:Escherichia coli / Q000187:drug effects / Q000254:growth & development; D005839:Gentamicins / Q000494:pharmacology; D006801:Humans; D008297:Male; D010406:Penicillins / Q000494:pharmacology; D013307:Streptomycin / Q000494:pharmacology
chemical_list: D005839:Gentamicins; D010406:Penicillins; D000362:Agar; D013307:Streptomycin